Found: 65
Select item for more details and to access through your institution.
Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various Minimum Inhibitory Concentrations.
- Published in:
- Journal of Pharmacy Practice, 2018, v. 31, n. 1, p. 34, doi. 10.1177/0897190017696950
- By:
- Publication type:
- Article
The Accessory Genome in Enterococcal Bacteremia: Results from the Vancomycin-Resistant Enterococcal Bacteremia Outcomes Study (VENOUS).
- Published in:
- Contacto Científico Clínica Alemana, 2019, v. 9, n. 3, p. 41
- By:
- Publication type:
- Article
Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer Center.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 5, p. 1, doi. 10.1093/ofid/ofae235
- By:
- Publication type:
- Article
Nut Cracked? Does the ACORN Trial End the Debate Surrounding Vancomycin and Piperacillin-Tazobactam Combination Therapy and Increased Risk for Acute Kidney Injury?
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 1, p. 1, doi. 10.1093/ofid/ofad645
- By:
- Publication type:
- Article
In Vivo Emergence of Pandrug-Resistant Acinetobacter baumannii Strain: Comprehensive Resistance Characterization and Compassionate Use of Sulbactam-Durlobactam.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Variation in Clinical Practice and Attitudes on Antibacterial Management of Fever and Neutropenia in Patients With Hematologic Malignancy: A Survey of Cancer Centers Across the United States.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 3, p. 1, doi. 10.1093/ofid/ofac005
- By:
- Publication type:
- Article
1719. Incidence and Characterization of Invasive Fungal Infections (IFIs) in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib (IBR).
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S630, doi. 10.1093/ofid/ofz360.1582
- By:
- Publication type:
- Article
622. The Accessory Genome in Enterococcal Bacteremia: Results from the Vancomycin-Resistant Enterococcal Bacteremia Outcomes Study (VENOUS).
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S289, doi. 10.1093/ofid/ofz360.690
- By:
- Publication type:
- Article
605. Identification of a Novel CMY-Variant Enzyme in a Clinical Escherichia coli Strain with Treatment-Emergent Ceftazidime–Avibactam Resistance.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S283, doi. 10.1093/ofid/ofz360.674
- By:
- Publication type:
- Article
2682. Prophylaxis-Driven Molecular Epidemiology of Pseudomonas aeruginosa Bloodstream Infections in Adults With Leukemia.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S942, doi. 10.1093/ofid/ofz360.2359
- By:
- Publication type:
- Article
2674. Microbiome and Cumulative Antibiotic Use as Predictors of Stenotrophomonas maltophilia Infection in Patients with Acute Myeloid Leukemia Receiving Remission-Induction Chemotherapy.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S938, doi. 10.1093/ofid/ofz360.2352
- By:
- Publication type:
- Article
2248. Clinical and Microbiological Outcomes Associated with Real-World Use of Ceftolozane/Tazobactam.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S768, doi. 10.1093/ofid/ofz360.1926
- By:
- Publication type:
- Article
2246. Improved Outcomes for Cancer Patients Treated With Ceftazidime–Avibactam vs. Polymyxin-Containing Regimens for Carbapenem-Resistant Enterobacteriaceae Bacteremia.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S768, doi. 10.1093/ofid/ofz360.1924
- By:
- Publication type:
- Article
1831. Machine Learning Approaches to Predicting Resistance in Pseudomonas aeruginosa.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S42, doi. 10.1093/ofid/ofz359.093
- By:
- Publication type:
- Article
Higher MICs (>2 mg/L) Predict 30-Day Mortality in Patients With Lower Respiratory Tract Infections Caused by Multidrug- and Extensively Drug-Resistant Pseudomonas aeruginosa Treated With Ceftolozane/Tazobactam.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 10, p. N.PAG, doi. 10.1093/ofid/ofz416
- By:
- Publication type:
- Article
Culture-Documented Invasive Mold Infections at MD Anderson Cancer Center in Houston, Texas, Pre– and Post–Hurricane Harvey.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 4, p. N.PAG, doi. 10.1093/ofid/ofz138
- By:
- Publication type:
- Article
Clinical Outcomes Associated With Linezolid Resistance in Leukemia Patients With Linezolid-Resistant Staphylococcus epidermidis Bacteremia.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 7, p. N.PAG, doi. 10.1093/ofid/ofy167
- By:
- Publication type:
- Article
Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 1, p. 209, doi. 10.1007/s40121-022-00722-9
- By:
- Publication type:
- Article
Precision pharmacotherapy: Integrating pharmacogenomics into clinical pharmacy practice.
- Published in:
- JACCP: Journal of the American College of Clinical Pharmacy, 2019, v. 2, n. 3, p. 303, doi. 10.1002/jac5.1118
- By:
- Publication type:
- Article
Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.848580
- By:
- Publication type:
- Article
Navigating manuscript assessment: The new practitioner's guide to primary literature peer review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 94, doi. 10.1177/1078155218761222
- By:
- Publication type:
- Article
Does Switching Norepinephrine to Phenylephrine in Septic Shock Complicated by Atrial Fibrillation With Rapid Ventricular Response Improve Time to Rate Control?
- Published in:
- Journal of Intensive Care Medicine, 2021, v. 36, n. 2, p. 191, doi. 10.1177/0885066619896292
- By:
- Publication type:
- Article
Extended Versus Short-Course Corticosteroid Taper Regimens in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Critically Ill Patients.
- Published in:
- Journal of Intensive Care Medicine, 2020, v. 35, n. 3, p. 257, doi. 10.1177/0885066617741470
- By:
- Publication type:
- Article
Healthcare Resource Utilization for Recurrent <i>Clostridium difficile</i> Infection in a Large University Hospital in Houston, Texas.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0102848
- By:
- Publication type:
- Article
Optimization of intravenous immune globulin use at a comprehensive cancer center.
- Published in:
- American Journal of Health-System Pharmacy, 2019, v. 76, p. S102, doi. 10.1093/ajhp/zxz233
- By:
- Publication type:
- Article
Solithromycin: A novel ketolide antibiotic.
- Published in:
- American Journal of Health-System Pharmacy, 2017, v. 74, n. 12, p. 875, doi. 10.2146/ajhp160934
- By:
- Publication type:
- Article
Significant publications on infectious diseases pharmacotherapy in 2015.
- Published in:
- American Journal of Health-System Pharmacy, 2017, v. 74, n. 4, p. 238, doi. 10.2146/ajhp160090
- By:
- Publication type:
- Article
Significant publications on infectious diseases pharmacotherapy in 2014.
- Published in:
- American Journal of Health-System Pharmacy, 2015, v. 72, n. 16, p. 1380, doi. 10.2146/ajhp150112
- By:
- Publication type:
- Article
Rh<sub>o</sub>D immune globulin products for prevention of alloimmunization during pregnancy.
- Published in:
- American Journal of Health-System Pharmacy, 2015, v. 72, n. 4, p. 267, doi. 10.2146/ajhp140288
- By:
- Publication type:
- Article
Prophylaxis Against Pneumocystis Pneumonia—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 19, p. 1909, doi. 10.1001/jama.2023.18865
- By:
- Publication type:
- Article
Prophylaxis Against Pneumocystis jirovecii Pneumonia in Adults.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 2, p. 182, doi. 10.1001/jama.2023.9844
- By:
- Publication type:
- Article
Evaluation of Fluoroquinolone Versus Other Antibiotic Prophylaxis Strategies in Adult Patients with AML Undergoing Induction Chemotherapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S5, doi. 10.1016/j.clml.2017.09.030
- By:
- Publication type:
- Article
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 2, p. 187, doi. 10.1093/cid/ciac268
- By:
- Publication type:
- Article
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 12, p. 2089, doi. 10.1093/cid/ciab1013
- By:
- Publication type:
- Article
Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 8, p. 1346, doi. 10.1093/cid/ciab298
- By:
- Publication type:
- Article
Clostridioides difficile Infection in Cancer and Immunocompromised Patients: Relevance of a Two-step Diagnostic Algorithm and Infecting Ribotypes on Clinical Outcomes.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 10, p. e460, doi. 10.1093/cid/ciaa1184
- By:
- Publication type:
- Article
Alterations of the Oral Microbiome and Cumulative Carbapenem Exposure Are Associated With Stenotrophomonas maltophilia Infection in Patients With Acute Myeloid Leukemia Receiving Chemotherapy.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 9, p. 1507, doi. 10.1093/cid/ciaa778
- By:
- Publication type:
- Article
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 7, p. 1109, doi. 10.1093/cid/ciab295
- By:
- Publication type:
- Article
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 7, p. e169, doi. 10.1093/cid/ciaa1478
- By:
- Publication type:
- Article
Reply to Cheng and Chuang.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Pharmacodynamic Analysis of Daptomycin-treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 10, p. 1650, doi. 10.1093/cid/ciy749
- By:
- Publication type:
- Article
Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 10, p. 1641, doi. 10.1093/cid/ciy760
- By:
- Publication type:
- Article
Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses.
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 3, p. 398, doi. 10.1093/cid/ciy089
- By:
- Publication type:
- Article
Whole-Genome Sequencing Accurately Identifies Resistance to Extended-Spectrum β-Lactams for Major Gram-Negative Bacterial Pathogens.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 5, p. 738, doi. 10.1093/cid/cix417
- By:
- Publication type:
- Article
Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 1, p. 158, doi. 10.1093/cid/cix014
- By:
- Publication type:
- Article
High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 7, p. 954, doi. 10.1093/cid/ciw398
- By:
- Publication type:
- Article
Treatment of Extended-Spectrum Beta-Lactamase Enterobacteriaceae With Cefepime: The Dose Matters, Too.
- Published in:
- 2013
- By:
- Publication type:
- Letter
#AMRrounds: a systematic educational approach for navigating bench to bedside antimicrobial resistance.
- Published in:
- JAC-Antimicrobial Resistance, 2023, v. 5, n. 4, p. 1, doi. 10.1093/jacamr/dlad097
- By:
- Publication type:
- Article
Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA.
- Published in:
- JAC-Antimicrobial Resistance, 2023, v. 5, n. 1, p. 1, doi. 10.1093/jacamr/dlac131
- By:
- Publication type:
- Article
The Growing Threat of NDM-Producing Escherichia coli With Penicillin-Binding Protein 3 Mutations in the United States—Is There a Potential Role for Durlobactam?
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 4, p. 834, doi. 10.1093/cid/ciae229
- By:
- Publication type:
- Article